ReShape Lifesciences

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Advaxis

Voyager Therapeutics

Are these high volume biotech penny stocks worth adding to your watchlist right now? The post Top Biotech Penny Stocks to Watch With High Volume Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Biotech Penny Stocks to Watch With High Volume Right Now

American Resources Corp

Kosmos Energy

Seanergy Maritime Hlds

Tellurian

Are these the best penny stocks to buy right now after analysts weighed in? The post Best Penny Stocks To Buy According To Analysts & Targets Up To 290% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy According To Analysts & Targets Up To 290%

SAN CLEMENTE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company was highlighted in this week's BioTuesdays feature article, titled “ReShape Lifesciences forging weight loss and metabolic health solutions”. The article stemmed from ReShape Lifesciences CEO Bart Bandy's interview with BioTuesdays' Editor in Chief Leonard Zehr.

ReShape Lifesciences™ Featured in BioTuesdays

Bridgeline Digital

Digital Brands Group Inc

Grove

Recon Technology

Penny stocks are incredibly risky. But if you must engage this sector, you certainly have a better chance with low-float securities.

7 Reddit Penny Stocks Dazzling Investors with Low Floats

SAN CLEMENTE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced that its leadership will present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit on Monday, September 20, 2021, at 2:05 p.m. ET.

ReShape Lifesciences™ to Present at Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit on September 20, 2021

Amplify Energy Corp.

Baudax Bio

Calyxt

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

5 Penny Stocks Insiders Are Buying

SAN CLEMENTE, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the appointment of Al Diaz as Vice President of Operations and Research and Development. Mr. Diaz will be responsible for overseeing the company's manufacturing operations and research and development efforts.

ReShape Lifesciences™ Appoints Al Diaz as Vice President of Operations and Research and Development

The shares of ReShape Lifesciences Inc (NASDAQ: RSLS) have received a $10.25 price target from Alliance Global Partners. These are the details.

ReShape Lifesciences Shares: $10.25 Target From Alliance Global Partners

The shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) increased by over 16% pre-market. This is why it happened.

ReShape Lifesciences Shares Increase Over 16% Pre-Market: Why It Happened

Atossa Genetics

Evofem Biosciences Inc

Biotech penny stocks continue to make headway, here's 3 with high volume right now The post 3 Biotech Penny Stocks With High Volume To Watch in August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks With High Volume To Watch in August

AcelRx Pharmaceuticals

Jaguar Health

22nd Century Group

Analysts say these are penny stocks to buy. Do you agree?

5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021

Webinar to follow at 8:30 a.m. today SAN CLEMENTE, CA / ACCESSWIRE / August 16, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today reported its financial and operational results for the three months ended June 30, 2021.

ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update

SAN CLEMENTE, CA / ACCESSWIRE / August 5, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today reported its preliminary unaudited financial and operational results for the three months ended June 30, 2021. For the three months ended June 30, 2021, the Company reported revenues of $3.5 million, as compared to revenues of $1.7 million in the three months ended June 30, 2020, representing a 107% increase.

ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update

SAN CLEMENTE, CA / ACCESSWIRE / August 3, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced CEO Bart Bandy's featured interview on the Big Biz Show, a local-San Diego business talk show. "We are grateful for the opportunity to talk with the hosts of the Big Biz Show, a program focused on giving a platform to businesses on a serial growth path.

ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show

Webinar will be available discussing recent major milestones that same day SAN CLEMENTE, CA / ACCESSWIRE / July 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company is scheduled to release its second quarter financial results on Thursday, August 5, 2021, before the financial markets open. "We look forward to announcing our significant events and results from the second quarter and providing a business update to our shareholders," commented Bart Bandy, President & Chief Executive Officer at ReShape Lifesciences.

ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021

Support.com

Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.

3 Short Squeeze Candidates Trading Under $5

Alset EHome International

Greenpro Capital Corp

Exela Technologies

Which Reddit penny stocks are investors watching right now? Check these 4 out for your list The post Popular Reddit Penny Stocks to Buy?

Popular Reddit Penny Stocks to Buy? 4 to Watch As Summer Continues

SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of ReShape Marketplace ™ as an extension of reshape care ™, the company's reimbursed telehealth service for weight loss across any physician prescribed therapy. ReShape Marketplace provides consumers with a collection of creative, competitively priced, yet practical wellness products in the areas of nutrition, exercise, sleep, and stress.

ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress

Iterum Therapeutics Plc

Verb Technology Company Inc

Looking for the best penny stocks to buy in 2021? Check these 7 out for your watchlist The post Are These Hot Penny Stocks Worth Buying Right Now?

Are These Hot Penny Stocks Worth Buying Right Now? 7 For Your List

The stock price of ReShape Lifesciences Inc (NASDAQ: RSLS) increased by over 10% pre-market. This is why it happened.

ReShape Lifesciences Stock Increases Over 10% Pre-Market: Why It Happened

SAN CLEMENTE, CA / ACCESSWIRE / July 7, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced it has completed their Lap-Band® manufacturing transition from Apollo Endosurgery, Inc to a Massachusetts-based manufacturer. ReShape Lifesciences™ expects this change to enable it to reduce costs, improve margins and directly control the manufacturing process.

ReShape Lifesciences Moves Lap-Band Manufacturing to United States

SAN CLEMENTE, CA / ACCESSWIRE / July 1, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight-loss solutions company, today announced that Lap-Band® utilization has increased since COVID-19 in response to patients' increased desire for a reimbursed, effective, and sustainable weight-loss procedure that can be provided in outpatient surgery centers. The Lap-Band is clinically proven to be the safest bariatric procedure available on the market, backed by over 20 years of data demonstrating lower complication and mortality rates compared to other surgical weight-loss procedures.

ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis

Funding provides for the acceleration of its internal growth strategy and the continued development of Reshape's weight-loss portfolio SAN CLEMENTE, CA / ACCESSWIRE / June 30, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a global physician-led weight-loss and metabolic health solutions company, today provided additional information about its previously announced warrant exercise agreement with existing accredited investors for approximately $46 million in gross proceeds. The company is currently anchored by the Lap-Band® System with over 1,000,000 worldwide placements and the company's recently launched reshapecare™ virtual health program, both reimbursed through major insurance carriers.

ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders

SAN CLEMENTE, CA / ACCESSWIRE / June 29, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), a global weight-loss solutions leader, announced today that it has entered into a warrant exercise agreement with existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 7.9 million shares of the company's common stock. In consideration for the immediate exercise of the existing warrants for cash, the exercising holders received new unregistered warrants to purchase up to an aggregate of 5.9 million shares (equal to 75% of the shares of common stock issued in connection with the exercise) of the company's common stock.

ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds

ReShape Life Sciences Inc (NASDAQ:RSLS) shares are trading higher Monday after hedge fund Armistice Capital reported it had a 50% ownership stake in the company. The stock was trending throughout the day on social media sites such as StockTwits.

News for ReShape Lifesciences Stock (RSLS)